Wuhan Biocause Pharmaceutical Development Co., Ltd

Company Description

Wuhan biocause pharmaceutical Development Co.,Ltd,established in 2002,is one of the subsidiary of Hubei biocause Pharmaceutical Co.,Ltd. It discoveries,develops,manufactures and markets many kinds of intermediates,APLs and drug formulations. As a new advanced technology enterprise in Wuhan,it is mainly in charge of importation and exportation of pharmaceutical products. The innovation policy,high-class production facilities and QA system gurantee all products are of the highest techniques and quality.some of the major products is fludarabine phosphate;granisetron hydrochloride;flumazenil;milrinone and cladribine etc. On 12,2004,the prodution line of Granisetron and fludarabine phosphate have got the FDA site inspection approval, zero 483 observation. Wuhan Biocause Pharmaceutical Development Co., Ltd true and sincere enough to make business partner world wide.